Abstract | BACKGROUND: Hypertensive disorders during pregnancy are important causes of maternal mortality and morbidity worldwide. The long-term outcome of surviving mothers will depend largely on whether intracranial haemorrhage or renal failure developed. Low-dose dopamine is used for the prevention and treatment of acute renal failure, but its role in the management of pregnant women with severe pre-eclampsia is unclear. OBJECTIVES: SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (June 2006). SELECTION CRITERIA: DATA COLLECTION AND ANALYSIS: The two review authors assessed trial quality and data independently. MAIN RESULTS: Only one randomised placebo controlled trial of six hours' duration, including 40 postpartum women, was found. This study showed a significant increase in urinary output over six hours in women receiving dopamine. It is unclear if this was of any benefit to the women. AUTHORS' CONCLUSIONS: It is unclear whether low-dose dopamine therapy for pre-eclamptic women with oliguria is worthwhile. It should not be used other than in prospective trials.
|
Authors | D W Steyn, P Steyn |
Journal | The Cochrane database of systematic reviews
(Cochrane Database Syst Rev)
Issue 1
Pg. CD003515
(Jan 24 2007)
ISSN: 1469-493X [Electronic] England |
PMID | 17253491
(Publication Type: Journal Article, Review, Systematic Review)
|
Chemical References |
|
Topics |
- Dopamine
(administration & dosage)
- Dopamine Agents
(administration & dosage)
- Female
- Humans
- Pre-Eclampsia
(drug therapy, physiopathology)
- Pregnancy
- Urination
|